"Fall-risk increasing drugs are commonly prescribed to people with COPD because they experience a high number of symptoms and conditions that indicate use of these drugs," said Cara L. McDermott, ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

Asthma–chronic obstructive pulmonary disease (COPD ... then to determine the best available therapy. The authors discuss the array of existing and emerging classes of drugs that could benefit ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

Although these products might confer significant advantages over the currently available treatments, there is still a huge unmet need for drugs that prevent the progression of COPD. Companies are ...

Unfortunately, these drugs don't work for everyone and ... 40 people in the world have experienced eosinophilic asthma or COPD flare-up. Under current best treatments, 30 of them will require ...

Tudorza and Duaklir are inhaled respiratory drugs for chronic obstructive pulmonary disease (COPD) – and at the time of the deal Tudorza (aclidinium bromide), a long-acting muscarinic agonist ...

According to the results of a trial in 42 countries, a drug therapy appears to reduce lung function loss in patients with moderate to severe chronic obstructive pulmonary disease (COPD).

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

The Swiss drug development company Windward Bio recently announced that ... TSLP has been found to play a key role in ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.